z-logo
Premium
Autophagy‐mediated chemosensitization by cysteamine in cancer cells
Author(s) -
Wan XiaoMei,
Zheng Fang,
Zhang Li,
Miao YanYan,
Man Na,
Wen LongPing
Publication year - 2011
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.25771
Subject(s) - autophagy , doxorubicin , cysteamine , hela , cytotoxicity , melanoma , cancer cell , cancer research , pharmacology , chemotherapy , chemistry , cell culture , medicine , biology , in vitro , cancer , biochemistry , apoptosis , genetics
Cysteamine (CS) has many biomedical and clinical applications because of its excellent water solubility, low cytotoxicity and good biocompatibility. A previous study by Brawer et al. reported the occurrence of many Gomori inclusion bodies in CS‐treated astrocytes, which would suggest the induction of autophagy. Here we provided a comprehensive line of evidence demonstrating that CS caused autophagosome accumulation in cancer cells. CS exerted a biphasic effect on the autophagy process, increasing the formation of autophagosomes in the early phase and blocking the autophagic degradation in a later phase. Furthermore, we showed that CS sensitized doxorubicin‐elicited chemotherapeutic killing in HeLa, B16 melanoma and doxorubicin‐resistant MCF‐7 cells and also enhanced chemotherapeutic efficacy of doxorubicin in a mouse melanoma model. Finally, we demonstrated that the chemosensitizing effect of CS was at least partly dependent on its ability to modulate autophagy. Our results revealed a novel biological function for CS in enhancing the chemotherapeutic effect of doxorubicin through autophagy modulation and pointed to the potential use of CS in adjunct cancer chemotherapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here